Study finds β-blockers may delay onset and slow progression of Huntington's disease, offering potential as a therapeutic strategy Study: β-Blocker Use and Delayed Onset and Progression of ...

What you should and shouldn’t do to help beta-blockers protect your heart health effectively while minimizing their possible ...

β-blockers may increase depression risk in heart attack survivors with normal heart function, questioning their necessity for this group. The REDUCE-AMI trial found long-term β-blocker use ...

The risk difference/100 persons exposed (RD 1000) associated with β-blocker use was 3.0, 2.1, and 1.0 for any major malformation, any cardiac malformation, and cleft lip or palate, respectively.

Of the participants, 309,978 received ARBs, 807,510 received ACEIs, 695,887 received β-blockers, and 448,589 received CCBs; the 1:1 PS-matched subgroups included 619,858 patients for ARB versus ...

References Steinman MA, Zullo AR, Lee Y, et al. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction.

Genetic or pharmacological blockade of ADRB1 with existing clinically approved drugs (β-blockers) prevented terminal exhaustion differentiation of T cells and increased T cell function in chronic ...

Researchers selected only patients who had been dispensed at least 1 ARB, ACE inhibitor, β-blocker, or CCB between January 2010 and December 2017.

Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous positive inotropic agents, vasodilators, or mechanical ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...